Doppler sonography and hepatic vein catheterization in portal hypertension: Assessment of agreement in evaluating severity and response to treatment

Journal of Hepatology

Volumn 28, Issue 4, 1998, Pages 622-630

  Merkel, Carlo ^a   Sacerdoti, David ^a   Bolognesi, Massimo ^a   Bombanato, Giancarlo ^a   Gatta, Angelo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Beta blockers; Congestion index; Hepatic venous pressure gradient; Isosorbide 5 mononitrate; Portal blood flow velocity; Portal vein

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ISOSORBIDE 5 NITRATE; NADOLOL;

ADULT; ARTICLE; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HEPATIC VEIN; HUMAN; LIVER CIRRHOSIS; MALE; PORTAL HYPERTENSION; PRIORITY JOURNAL; VEIN CATHETERIZATION; VENOUS PRESSURE;

EID: 0031961611     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(98)80286-9     Document Type: Article

References (47)

1. Lebrec D. Methods to evaluate portal hypertension. Gastroenterol Clin North Am. 21:1992;41-59.
2. Armonis A, Patch D, Burroughs AK. Hepatic venous pressure measurement: an old test as a new prognostic marker in cirrhosis? Hepatology. 25:1997;245-248.
3. Vinel JP, Cassigneul J, Louis A, Levade M, Pascal JP. Clinical and prognostic significance of portohepatic gradient in patients with cirrhosis. Surg Gynecol Obstet. 155:1982;347-352.
4. Gluud C, Henriksen JH, Nielsen G. Prognostic indicators in alcoholic cirrhotic men. Hepatology. 8:1988;222-227.
5. Merkel C, Bolognesi M, Bellon S, Zuin R, Noventa F, Finucci G, et al. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology. 102:1992;973-979.
6. Vorobioff J, Groszmann RJ, Picabea E, Gamen M, Villavicencio R, Bordato J, et al. Prognostic value of hepatic venous pressure gradient measurement in alcoholic cirrhosis. A 10-year prospective study. Gastroenterology. 111:1996;701-709.
7. Baulieux J, Berlier JL, Maillet PJ, Peix JL, Girard D, Boulez J, et al. Mesure précoce de la pression portale pour le traitement des rupture de varices oesophagiennes. Nouv Press Mèd. 10:1981;3217-3220.
8. Vinel JP, Cassigneul J, Levade M, Voigt JJ, Pascal JP. Assessment of short-term prognosis after variceal bleeding in patients with alcoholic cirrhosis by early measurement of portohepatic gradient. Hepatology. 6:1986;116-117.
9. Ready JB, Robertson AD, Goff JS, Rector WG. Assessment of risk of bleeding from esophageal varices by continuous monitoring of portal pressure. Gastroenterology. 10:1991;1403-1410.
10. Groszmann RJ, Bosch J, Grace N, Conn HO, Garcia-Tsao G, Navasa M, et al. Hemodynamic events in a prospective randomized trial of propranolol vs. placebo in the prevention of the first variceal hemorrhage. Hepatology. 99:1990;1401-1407.
11. Sacerdoti D, Merkel C, Gatta A. Importance of the 1-month effect of nadolol on portal pressure in predicting failure of prevention of rebleeding in cirrhosis. J Hepatol. 12:1991;124-125.
12. Feu F, Garcia-Pagan JC, Bosch J, Luca A, Terés J, Escorsell A, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet. 346:1995;1056-1059.
13. Villanueva C, Balanzò J, Novella MT, Soriano G, Sàinz S, Torras X, et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med. 334:1996;1624-1629.
14. Moriyasu F, Nishida O, Ban N, Nakamura T, Sakai M, Miyake T, et al. "Congestion index" of the portal vein. Am J Roentgenol. 146:1986;735-739.
15. Zironi G, Gaiani S, Fenyves D, Rigamonti A, Bolondi L, Barbara L. Value of measurement of portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertension. J Hepatol. 16:1992;298-303.
16. Sacerdoti D, Merkel C, Bolognesi M, Amodio P, Angeli P, Gatta A. Hepatic arterial resistance in cirrhosis with and without portal vein thrombosis: relationships with portal hemodynamics. Gastroenterology. 108:1995;1152-1158.
17. Zoli M, Marchesini G, Brunori A, Cordiani MR, Pisi E. Portal venous flow response to acute beta-blocker and vasodilatory treatment in patients with liver cirrhosis. Hepatology. 6:1986;1248-1251.
18. Alvarez D, Mastai R, Lennié E, Soifer G, Levi D, Terg R. Noninvasive measurement of portal venous blood flow in patients with cirrhosis: effects of physiological and pharmacological stimuli. Dig Dis Sci. 36:1991;82-86.
19. Tincani E, Cioni G, Cristani A, D'Alimonte P, Vignoli A, Abbati G, et al. Duplex Doppler ultrasonographic comparison of the effects of propranolol and isosorbide-5-mononitrate on portal hemodynamics. J Ultrasound Med. 12:1993;525-529.
20. Bolognesi M, Sacerdoti D, Merkel C, Gatta A. Duplex Doppler sonographic evaluation of splanchnic and renal effects of single agent and combined therapy with nadolol and isosorbide-5-mononitrate in cirrhotic patients. J Ultrasound Med. 13:1994;945-952.
21. Viudez P, Castano G, Carlevaro O, Ocampo C, Zandalazini H, Riccitelli M, et al. Comparative study between Duplex-Doppler U.S. and invasive hemodynamic measurements: response to i.v. propranolol in cirrhotic patients with portal hypertension. [abstract] Hepatology. 24:1996;205.
22. Albillos A, Paramo MP, Cacho G, Iborra J, Calleja JL, Millàn I, et al. Accuracy of portal and forearm blood flow measurements in the assessment of portal pressure response to propranolol. J Hepatol. 27:1997;496-504.
23. Vorobioff J, Picabea E, Villavicencio R, Puccini V, Rossi O, Bordato J, et al. Acute and chronic hemodynamic effects of propranolol in unselected cirrhotic patients. Hepatology. 7:1987;648-653.
24. Merkel C, Sacerdoti D, Bolognesi M, Enzo E, Marin R, Bombonato G, et al. Hemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to the β-blocker alone. Hepatology. 26:1997;34-39.
25. Sabbà C, Merkel C, Zoli M, Ferraioli G, Gaiani S, Sacerdoti D, et al. Interobserver and interequipment variability of echo-Doppler examination of the portal vein: effect of a co-operative training program. Hepatology. 21:1995;428-433.
26. Moriyasu F, Ban N, Nishida O, Nakamura T, Miyake T, Uchino H, et al. Clinical application of a ultrasonic duplex system in the quantitative measurement of portal blood flow. J Clin Ultrasound. 14:1986;579-588.
27. Bolognesi M, Sacerdoti D, Merkel C, Bombonato G, Enzo E, Gatta A. Effects of chronic therapy with nadolol on portal hemoynamics and on splanchnic impedance indices using Doppler sonography: comparison between acute and chronic effects. J Hepatol. 26:1997;305-311.
28. Reynolds TB, Ito S, Iwatsuki S. Measurement of portal pressure and its clinical application. Am J Med. 49:1970;649-657.
29. Lin HC, Tsai YT, Lee FY, Chang TT, Wang SS, Lay CS, et al. Comparison between portal vein pressure and wedged hepatic vein pressure in hepatitis B-related cirrhosis. J Hepatol. 9:1989;326-330.
30. Garcia-Tsao G, Groszmann RJ, Fisher RL, Conn HO, Atterbury CE, GLickmann N. Portal pressure, presence of esophageal varices, and variceal bleeding. Hepatology. 5:1985;419-424.
31. Fleiss JL. 2nd ed. Statistical Methods for Rates and Proportions. 1981;212-236 Wiley, New York.
32. Galen RS, Gambino SR. Beyond Normality: the Predictive Value and Efficiency of Medical Diagnoses. 1988;Wiley, New York.
33. Sacerdoti D, Bolognesi M, Bombonato GC, Gatta A. Paraumbilical vein patency in cirrhosis: effect on hepatic hemodynamics evaluated by Doppler sonography. Hepatology. 22:1995;1689-1693.
34. Luca A, Garcia-Pagan JC, Feu F, Lopez-Talavera JC, Fernandez M, Bru C, et al. Noninvasive measurement of femoral blood flow and portal pressure response to propranolol in patients with cirrhosis. Hepatology. 21:1995;83-88.
35. Barbara L. The value of Doppler US in the study of hepatic hemodynamics. Consensus conference. J Hepatol. 10:1990;353-355.
36. Dokmeci AK, Kimura K, Matsutani S, Ohto M, Ono T, Tsuchiya Y, et al. Collateral veins in portal hypertension: demonstration by sonography. Am J Roentgenol. 137:1981;1173-1177.
37. Gaiani S, Bolondi L, Fenyves D, Zironi G, Rigamonti A, Barbara L. Effect of propranolol on portosystemic collateral circulation in patients with cirrhosis. Hepatology. 14:1991;824-829.
38. Weltin G, Taylor KJW, Carter AR, Taylor CR. Duplex Doppler identification of cavernomatous transformation of the portal vein. Am J Roentgenol. 144:1984;999-1001.
39. Goyal AK, Pokharma DS, Sharma SK. Ultrasonic measurement of portal vasculature in the diagnosis of portal hypertension. A controversial subject reviewed. J Ultrasound Med. 9:1990;45-48.
40. Zoli M, Marchesini G, Cordiani MR, Pisi P, Brunori A, Trono A, et al. Echo-Doppler measurement of splanchnic blood flow in control and cirrhotic subjects. J Clin Ultrasound. 14:1986;429-435.
41. Siringo S, Bolondi L, Gaiani S, Sofia S, Di Febo G, Zironi G, et al. The relationship of endoscopy, portal Doppler flowmetry, and clinical and biochemical tests in cirrhosis. J Hepatol. 20:1994;11-18.
42. Garcia-Pagan JC, Feu F, Bosch J, Rodés J. Propranolol compared with propranolol plus isosorbide-5-mononitrate for portal hypertension in cirrhosis: a randomized controlled study. Ann Intern Med. 114:1991;869-873.
43. Merkel C, Gatta A, Donada C, Enzo E, Marin R, Amodio P, et al. Long-term effect of nadolol or nadolol plus isosorbide-5-mononitrate on renal function and ascites formation in patients with cirrhosis. Hepatology. 22:1995;808-813.
44. Merkel C, Marin R, Enzo E, Donada C, Cavallarin G, Torboli P, et al. Randomised trial of nadolol alone or with isosorbide mononitrate for primary prophylaxis of variceal bleeding in cirrhosis. Lancet. 348:1996;1677-1681.
45. Kroeger RJ, Groszmann RJ. Increased portal venous resistance hinders portal pressure reduction during the administration of beta-adrenergic blocking agents in a portal hypertensive model. Hepatology. 5:1985;97-101.
46. Sabbà C, Weltin G, Cicchetti DV, Ferraioli G, Taylor KJW, Nakamura T, et al. Observer variability in echo-Doppler measurements of portal flow in cirrhotic patients and normal volunteers. Gastroenterology. 98:1990;1603-1611.
47. Valla D, Jiron D, Poynard T, Braillon A, Lebrec D. Failure of hemodynamic measurements to predict recurrent gastrointestinal bleeding in cirrhotic patients receiving propranolol. J Hepatol. 5:1987;144-148.